Demethylating Agent Azacitidine on Prevention of Acute Kidney Injury-chronic Kidney Disease Continuum

NCT05325099 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Acute Kidney Disease

Interventions

DRUG: Azacitidine
DRUG: Placebo

Sponsor

National Taiwan University Hospital